Starsource Multitrade

Sector: Healthcare

Followers

2
2
2
2
.
1
1
1
1
1
1
5.25 (4.95%)

As on 30 Mar, 2026 | 16:01

Open Trading A/c
Day Range
108.50
111.26
LH
52 Week Range
75.00
152.90
LH
Volume
* i
Bid / Ask
236.00
0.00 / 0.00

Starsource Multitrade Announcements

The Exchange has sought clarification from Star Source Multi Trade Ltd on March 30, 2026 with reference to significant movement in price, in order to...

30 Mar, 2026 | 06:39pm • Source: BSE

Closure of Trading Window for the Quarter ended on March 31, 2026.

30 Mar, 2026 | 04:52pm • Source: BSE

Revised Outcome of Board Meeting held on February 12, 2026. (Correction in typo of outcome Time). Correct time is 12:45 PM.

16 Feb, 2026 | 07:19pm • Source: BSE

Newspaper publication regarding unaudited quarterly Financial Results for the quarter and nine months ended December 31, 2025.

13 Feb, 2026 | 01:30pm • Source: BSE

Result for the Quarter and Nine Months Ended December 31m 2025.

12 Feb, 2026 | 01:17pm • Source: BSE

Unaudited Financial Results for the quarter and nine months ended December 31, 2025

12 Feb, 2026 | 01:03pm • Source: BSE

Star Source Multi Trade Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to...

09 Feb, 2026 | 04:18pm • Source: BSE

Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the Quarter ended December 31, 2025.

12 Jan, 2026 | 04:15pm • Source: BSE

Declaration of Non-Applicability of Regulation 23(9) of SEBI (LODR) Regulations, 2015 - December 31, 2025 Quarter

06 Jan, 2026 | 12:19pm • Source: BSE

Change in Domain name of website of the Company

05 Jan, 2026 | 03:54pm • Source: BSE

Closure of Trading Window for the Quarter ended December 31, 2025

28 Dec, 2025 | 01:04pm • Source: BSE

With reference to our earlier announcement dated April 16, 2025 regarding resignation of CEO/CFO & CS-CO, we submit herewith required details under SEBI Circular No....

26 Dec, 2025 | 04:26pm • Source: BSE

Newspaper Publication of Unaudited Financial Results for the period ended September 30, 2025

14 Nov, 2025 | 03:20pm • Source: BSE

Star Source Multi Trade Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to...

10 Nov, 2025 | 11:50am • Source: BSE

The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shanta Somani

16 Oct, 2025 | 12:57pm • Source: BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shanta Somani & PAC

14 Oct, 2025 | 05:18pm • Source: BSE

Declaration of Non-Applicability of Regulation 23(9) of SEBI (LODR) Regulations, 2015 - September 2025 Quarter

10 Oct, 2025 | 02:01pm • Source: BSE

Compliance Certificate under Regulation 74(5) of SEBP (DP) Regulations 2018 for the Quarter ended September 30, 2025

10 Oct, 2025 | 12:25pm • Source: BSE

Change of name of Company from Chemo Pharma Laboratories Limited to Starsource Multitrade Limited.

01 Oct, 2025 | 04:56pm • Source: BSE

Intimation of Closure of Trading Window

25 Sep, 2025 | 06:29pm • Source: BSE